Triple

T1143394
Position Surface form Disambiguated ID Type / Status
Subject Heads of Medicines Agencies E23506 entity
Predicate hasWorkingGroup P1382 FINISHED
Object Heads of Medicines Agencies Clinical Trials Coordination Group E23506 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Heads of Medicines Agencies Clinical Trials Coordination Group | Statement: [Heads of Medicines Agencies, hasWorkingGroup, Heads of Medicines Agencies Clinical Trials Coordination Group]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Heads of Medicines Agencies Clinical Trials Coordination Group
Context triple: [Heads of Medicines Agencies, hasWorkingGroup, Heads of Medicines Agencies Clinical Trials Coordination Group]
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. Heads of Medicines Agencies chosen
    Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
  • C. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • D. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • E. Committee for Orphan Medicinal Products
    The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493ef399c8190b04b9146d2314f59 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4bc4e93d48190b9fea886bf61aad7 completed March 1, 2026, 10:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac59b2395c81909d4608bdaf1d57e8 completed March 7, 2026, 5 p.m.
Created at: March 1, 2026, 7:44 p.m.